 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/16/2024 |
$1.83 |
$1.84 |
$1.69 |
$1.70 |
4.59M | | 04/17/2024 |
$1.72 |
$1.78 |
$1.61 |
$1.62 |
5.56M | | 04/18/2024 |
$1.67 |
$1.73 |
$1.62 |
$1.63 |
3.71M | | 04/19/2024 |
$1.63 |
$1.69 |
$1.60 |
$1.65 |
2.99M | | 04/22/2024 |
$1.68 |
$1.86 |
$1.67 |
$1.71 |
4.08M |
|
|
| Lexicon Pharmaceuticals is a biopharmaceutical company. Co. discovers the functions and pharmaceutical utility of genes and uses those gene function discoveries in the discovery and development of pharmaceutical products for the treatment of human disease. Co. is also developing sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes. Co. is developing LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain. In addition, Co. is conducting preclinical research and development and preparing to conduct clinical development of compounds from several additional drug programs. | |
|
Lexicon Pharmaceuticals (LXRX) has the following price history information. Looking back at LXRX historical stock prices for the last five trading days, on April 16, 2024, LXRX opened at $1.83, traded as high as $1.84 and as low as $1.69, and closed at $1.70. Trading volume was a total of 4.59M shares. On April 17, 2024, LXRX opened at $1.72, traded as high as $1.78 and as low as $1.61, and closed at $1.62. Trading volume was a total of 5.56M shares. On April 18, 2024, LXRX opened at $1.67, traded as high as $1.73 and as low as $1.62, and closed at $1.63. Trading volume was a total of 3.71M shares. On April 19, 2024, LXRX opened at $1.63, traded as high as $1.69 and as low as $1.60, and closed at $1.65. Trading volume was a total of 2.99M shares. On April 22, 2024, LXRX opened at $1.68, traded as high as $1.86 and as low as $1.67, and closed at $1.71. Trading volume was a total of 4.08M shares.
LXRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Lexicon Pharmaceuticals shares, starting with a $10,000 purchase of LXRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/24/2014 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$10.92 |
|
| End price/share: |
$1.71 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-84.34% |
|
| Average Annual Total Return: |
-16.92% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,565.83 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/16/2024 | $1.70 | | 04/17/2024 | $1.62 | | 04/18/2024 | $1.63 | | 04/19/2024 | $1.65 | | 04/22/2024 | $1.71 |
|
|
Free LXRX Email Alerts:
